Description: Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others. It offers endoscopic video endoscopy systems, endoscopic ultrasound systems, ultrasound endoscopes and probes, endoscopic ultrasound observation devices, capsule endoscopy systems, integrated documentation systems, therapeutic equipment, and ancillary products; cleaning, disinfecting, and sterilization systems; gastrointestinal, colono, duodeno, and broncho endoscopes; endoscopy products for gastroenterological surgery, bronchial surgery, urology, gynecology, orthopedic surgery, neurosurgery, and anesthesiology, as well as ear, nose, and throat; and therapeutic and surgical equipment, endoscope ancillary equipment, and endotherapy devices. The company also provides upright, polarizing, inverted, laser scanning confocal, stereo, and marco fluorescence microscopes; box-type fluorescence imaging devices, microscope digital cameras, life science imaging software, bio-imaging systems, and virtual slide systems; metallurgical, semiconductor and flat-panel display inspection, laser scanning, and measuring microscopes; microscopic 3D measurement instruments, and industrial microscope ancillary equipment; and industrial videoscopes and fiberscopes, industrial rigidscopes and ancillary equipment, ultrasonic flaw detectors, eddy current and phased array flaw detectors, and X-ray fluorescence and X-ray diffraction analyzers. In addition, it offers interchangeable lens cameras, compact digital cameras, digital camera accessories, lens barrels units, optical components, digital audio recorders, binoculars, and related software applications; and biomedical materials system. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.
Home Page: www.olympus-global.com
Shinjuku Monolith
Tokyo,
163-0914
Japan
Phone:
81 3 3340 2111
Officers
| Name | Title |
|---|---|
| Mr. Yasuo Takeuchi | Pres, CEO, Representative Exec. Officer & Director |
| Mr. Stefan Kaufmann | Exec. Officer, Chief Admin. Officer, Chief Strategy Officer, ESG Officer & Director |
| Mr. Chikashi Takeda | Exec. Officer & CFO |
| Mr. Nacho Abia | COO & Exec. Officer |
| Mr. Andre Roggan | Exec. Officer & CTO |
| Stephen Kneebone | Corp. Officer & Chief Information Officer |
| Takaaki Sakurai | VP of Investor Relations |
| Ms. Donna Miller | Head of HQ Legal and Global Gen. Counsel |
| Shigeto Ohtsuki | Corp. Officer & HR Head |
| Mr. Tetsuo Kobayashi | Exec. Officer and Chief Manufacturing & Supply Officer |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 19.8413 |
|---|---|
| Trailing PE: | 24.6216 |
| Price-to-Book MRQ: | 5.2731 |
| Price-to-Sales TTM: | 0.0259 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 31557 |